Search Results - "Stadlbauer, V."

Immunosuppression and probiotics: are they effective and safe? by Stadlbauer, V

“…This opinion statement discusses indications, efficacy and safety of probiotics in immunosuppressed patients. The best evidence available is for the…”
Get more information

The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis by Kump, P., Wurm, P., Gröchenig, H. P., Wenzl, H., Petritsch, W., Halwachs, B., Wagner, M., Stadlbauer, V., Eherer, A., Hoffmann, K. M., Deutschmann, A., Reicht, G., Reiter, L., Slawitsch, P., Gorkiewicz, G., Högenauer, C.

“…Summary Background Faecal microbiota transplantation is an experimental approach for the treatment of patients with ulcerative colitis. Although there is…”
Get full text

When is it considered reasonable to start a risky and uncomfortable treatment in critically ill patients? A random sample online questionnaire study by Zink, M, Horvath, A, Stadlbauer, V

“…Health care professionals have to judge the appropriateness of treatment in critical care on a daily basis. There is general consensus that critical care…”
Get full text

Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis by Horvath, A., Leber, B., Schmerboeck, B., Tawdrous, M., Zettel, G., Hartl, A., Madl, T., Stryeck, S., Fuchs, D., Lemesch, S., Douschan, P., Krones, E., Spindelboeck, W., Durchschein, F., Rainer, F., Zollner, G., Stauber, R. E., Fickert, P., Stiegler, P., Stadlbauer, V.

“…Summary Background Probiotics may correct intestinal dysbiosis and proinflammatory conditions in patients with liver cirrhosis. Aim To test the effects of a…”
Get full text

Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation by Rainer, F., Horvath, A., Sandahl, T. D., Leber, B., Schmerboeck, B., Blesl, A., Groselj‐Strele, A., Stauber, R. E., Fickert, P., Stiegler, P., Møller, H. J., Grønbæk, H., Stadlbauer, V.

“…Summary Background Activated hepatic macrophages play a key role in inflammation and fibrosis progression in chronic liver disease. Aim To assess the…”
Get full text

MicroRNAs 223-3p and 93-5p in patients with chronic kidney disease before and after renal transplantation by Ulbing, M., Kirsch, A.H., Leber, B., Lemesch, S., Münzker, J., Schweighofer, N., Hofer, D., Trummer, O., Rosenkranz, AR, Müller, H., Eller, K., Stadlbauer, V., Obermayer-Pietsch, B.

“…Chronic kidney disease (CKD) is associated with a multifactorial dysregulation of bone and vascular calcification and closely linked to increased…”
Get full text

The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study by Leber, B, Tripolt, N J, Blattl, D, Eder, M, Wascher, T C, Pieber, T R, Stauber, R, Sourij, H, Oettl, K, Stadlbauer, V

“…Background/objectives: Obesity and metabolic disorders are linked to inflammation via gut microbiota and/or gut permeability. Gut-derived endotoxin triggers…”
Get full text

Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome--a pilot study by Tripolt, N J, Leber, B, Blattl, D, Eder, M, Wonisch, W, Scharnagl, H, Stojakovic, T, Obermayer-Pietsch, B, Wascher, T C, Pieber, T R, Stadlbauer, V, Sourij, H

“…Based on animal studies, intake of probiotic bacteria was suggested to improve insulin sensitivity by reducing endotoxinemia and inflammation. The objective of…”
Get more information

Liver disease alters high-density lipoprotein composition, metabolism and function by Trieb, M, Stadlbauer, V, Birner-Gruenberger, R, Marsche, G

Get full text

The Albicc Model: A new Prognostic Tool for Prediction of Short-Term Survival in Patients with End-Stage Liver Disease by Stauber, R.E, Haas, J, Wagner, D, Kniepeiss, D, Stadlbauer, V, Ferlitsch, A, Fuhrmann, V

Get full text

Drop of FGF19 levels in patients with HCC development following DAA therapy for chronic hepatitis C by Stadlbauer, V, Schmerböck, B, Leber, B, Kipperer, M, Stiegler, P, Posch, A, Streit, A, Spindelböck, W, Fickert, P, Stauber, R

Get full text

Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis by Stadlbauer, V, Mookerjee, R P, Wright, G A K, Davies, N A, Jürgens, G, Hallström, S, Jalan, R

“…Neutrophil dysfunction in alcoholic hepatitis is associated with endotoxemia and an increased incidence of infection, but the mechanism is unclear. We aimed to…”
Get more information

Exercise capacity and exercise hemodynamics in the screening for pulmonary vascular disease (PVD) in patients with portal hypertension – results from a prospective cross-sectional study by Douschan, P, Kovacs, G, Stadlbauer, V, Kniepeiss, D, Krones, E, Durchschein, F, Rainer, F, Spindelböck, W, Wagner, M, Zollner, G, Avian, A, Fickert, P, Olschewski, A, Olschewski, H, Stauber, R.E

Get full text

Direct acting antivirals improve neutrophil phagocytic capacity in chronic hepatitis C by Leber, B, Horvath, A, Schmerböck, B, Tawdrous, M, Streit, A, Posch, A, Fickert, P, Spindelböck, W, Stiegler, P, Stauber, R.E, Stadlbauer, V

Get full text

NOD2 variants as novel genetic risk factors for secondary sclerosing cholangitis in critically ill patients by Jüngst, C, Stadlbauer, V, Reichert, M, Weber, S, Ofner-Ziegenfuß, L, Voigtländer, T, Spindelböck, W, Fickert, P, Kirchner, G, Lammert, F, Lankisch, T.O, Krawczyk, M

Get full text

Intestinal colonisation by Veillonella spp. is predictive for mortality in stable cirrhosis and could be partially reduced by a multispecies probiotic in a randomized placebo controlled trial by Horvath, A, Bashir, M, Schmerboeck, B, Rainer, F, Krones, E, Baumann-Durchschein, F, Douschan, P, Spindelboeck, W, Zollner, G, Stauber, R.E, Fickert, P, Stiegler, P, Leber, B, Stadlbauer, V

Get full text

Dysbiosis of the gut microbiota and increased gut permeability characterize secondary sclerosing cholangitis in critically ill patients (SSC-CIP) by Blesl, A, Horvath, A, Jüngst, C, Leber, B, Schmerboeck, B, Tawdrous, M, Stiegler, P, Rainer, F, Spindelboeck, W, Fickert, P, Lammert, F, Reichert, M, Stadlbauer, V

Get full text

Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosis by Rainer, F, Horvath, A, Sandahl, T.D, Leber, B, Schmerboeck, B, Blesl, A, Krones, E, Baumann-Durchschein, F, Douschan, P, Spindelboeck, W, Zollner, G, Stauber, R.E, Fickert, P, Stiegler, P, Møller, H.J, Grønbæk, H, Stadlbauer, V

Get full text

P0992 : Metabolic disturbances after fructose overconsumption are not linked to intestinal permeability in healthy young volunteers by Kienbacher, C, Dolak, W, Traussnigg, S, Steindl-Munda, P, Oettl, K, Stadlbauer, V, Knapp, S, Vogelsang, H, Trauner, M

Get full text

Multispecies Probiotic Maintains Health Related Quality of Life in Cirrhosis Better than Placebo by Horvath, A, Leber, B, Fuchs, D, Schmerboeck, B, Tawdrous, M, Yueksel, O, Sherzay, K, Hartl, A, Lemesch, S, Spindelboeck, W, Fickert, P, Stauber, R.E, Stiegler, P, Durchschein, F, Krones, E, Douschan, P, Zollner, G, Stadlbauer, V

Get full text